106 related articles for article (PubMed ID: 6694537)
1. [Characteristics of metastatic lesions of the ribs from various sites of primary tumor process].
Gabuniia RI; Godin VP
Med Radiol (Mosk); 1984 Jan; 29(1):10-4. PubMed ID: 6694537
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and surgical treatment of metastatic lung tumors].
Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
[TBL] [Abstract][Full Text] [Related]
4. [Course of illness in malignant primary tumors with skeletal metastases].
Kolles H; Schmitt O
Z Orthop Ihre Grenzgeb; 1987; 125(5):513-7. PubMed ID: 3433906
[TBL] [Abstract][Full Text] [Related]
5. Importance of biopsy of new bone lesions in patients with previous carcinoma.
Clayer M; Duncan W
Clin Orthop Relat Res; 2006 Oct; 451():208-11. PubMed ID: 16801861
[TBL] [Abstract][Full Text] [Related]
6. Metastatic tumors to the nail unit: subungual metastases.
Cohen PR
Dermatol Surg; 2001 Mar; 27(3):280-93. PubMed ID: 11277898
[TBL] [Abstract][Full Text] [Related]
7. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
8. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
9. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
Vincent-Salomon A; Jouve M; Genin P; Fréneaux P; Sigal-Zafrani B; Caly M; Beuzeboc P; Pouillart P; Sastre-Garau X
Cancer; 2002 Apr; 94(8):2169-73. PubMed ID: 12001113
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
11. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
12. [Histopathology of metastatic bone tumors].
Moriwaki S
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1680-7. PubMed ID: 3592709
[TBL] [Abstract][Full Text] [Related]
13. Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients.
Massard G; Roeslin N; Jung GM; Dumont P; Wihlm JM; Morand G
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):218-27. PubMed ID: 8393506
[TBL] [Abstract][Full Text] [Related]
14. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
[TBL] [Abstract][Full Text] [Related]
15. Metastatic bone tumours.
Mysorekar VV; Dandekar CP; Rao SG
J Indian Med Assoc; 1998 Mar; 96(3):74-6. PubMed ID: 9828548
[TBL] [Abstract][Full Text] [Related]
16. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature.
Shen ML; Kang J; Wen YL; Ying WM; Yi J; Hua CG; Tang XF; Wen YM
J Oral Maxillofac Surg; 2009 Apr; 67(4):718-37. PubMed ID: 19304027
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers in skeletal metastasis.
Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
[TBL] [Abstract][Full Text] [Related]
18. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
20. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
